This Cholesterol Drug Can Reduce Risk Of Heart Attacks but Costs $15000
20 March, 2017, 12:40 | Author: Oscar Goodwin
In the research paper, the scientists show how one heart attack or stroke was prevented for every 74 patients taking the drug in the two-year trial. Given that many patients at risk of a heart attack or stroke have little else to try, he says, this is "absolutely an advance in cardiovascular medicine".
The larger reductions in heart attacks and strokes drove the drug's performance on the MACE measure, and on the primary endpoint, which comprised the MACE numbers as well as hospitalization for unstable angina and coronary revascularization procedures, Levy said.
PCSK9 inhibitors and statins start lowering LDL cholesterol nearly right away, but the beneficial effects on harder outcomes like heart attack and stroke take longer to emerge in clinical studies.
The data also show similar clinical benefit with evolocumab when analyzed according to baseline LDL levels, even in patients in the lowest quartile of baseline LDL cholesterol, in whom evolocumab reduced LDL cholesterol from 73 to 22 mg/dL. After 2 years, 9.8% of patients in the treatment group had at least one such event, versus 11.3% in the placebo group, the team revealed today in The New England Journal of Medicine and at a meeting of the American College of Cardiology in Washington, D.C. All of them were already receiving statin therapy. They followed-up these people for two years, from 2013 to 2015.
Stubbornly high cholesterol is a key risk factor. Instead, it had only been tested in laboratory trials.
The much anticipated study, titled ORION-1, was presented March 17 at American College of Cardiology's 66th Annual Scientific Session.
Repatha cut the combined risk of heart attacks, strokes and heart-related death by 20 per cent compared with a placebo in patients already on high doses of cholesterol-lowering statins, such at Lipitor.
Around 15m people die each year from heart attacks or stroke and Yorkshire has the highest levels of cardiovascular disease in the country.
And with a price tag of $15,000 per patient per year, that question for third-party payers will be significant.
This treatment has not been approved for all kind of patients.
Patients report few side effects from Repatha, which acts differently than statins and does not cause the muscle pain and weakness that some statin users experience.
Those benefits are clinically significant, not just statistically significant, and in a conference call hosted by Mizuho Securities USA Inc.'s senior biotech analyst Salim Syed, James Underberg, a clinical assistant professor of medicine at New York University Medical School and president-elect of the national lipid association, stressed the good news about the results.
The FOURIER trial (Further Cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk) was created to determine whether evolocumab, when added to statin therapy, would reduce adverse cardiovascular events. Evolocumab is a monoclonal antibody created to inhibit proprotein convertase subtillsin-kexin type 9 (PCSK9) and lower low-density lipoprotein (LDL) cholesterol levels to approximately 60%.
The company said it plans to begin enrolling patients in a pivotal Phase III study for the drug, inclisiran, later this year. The drugs work by blocking a protein that affects the liver's ability to remove cholesterol from the blood.
Evolocumab is part of a new class of drugs called PCSK9 inhibitors, which are monoclonal antibodies that help lower cholesterol.
Another study focused on evolocumab's effects on the cognitive function showed that there was no difference between the placebo group and the patients receiving evolocumab in the working memory, memory function and psychomotor speed.
Chinese smartphone maker Nubia had showcased the Z11 Mini S at MWC 2017 last month, and has now launched the smartphone in India. The nubia Z11 Mini S is the improved version of the nubia Z11 Mini launched in October past year for Rs 12,999.
Meanwhile, Minister of Tourism, Arts and Culture, Catherine Afeku, has offered her condolences to the families of the victims. He said 11 people were receiving treatment, including one of the school administrators in charge of the trip.
The chance of rain continues for Wednesday but right now it doesn't appear as if it will be all that heavy or last for very long. After a chilly morning with temperatures in the low 30s, Monday is looking to be the warmest day of this coming week.
The two Sufi clerics of Delhi's Hazrat Nizamuddin Dargah, who had gone missing in Pakistan have returned safely to India. Due to absence of communication, people got anxious which further led to rumours that "we have been kidnapped".
And if Trump refuses to cooperate with Obama-instated refugee caps, he will be in violation of a court order. The cap "draws no distinction whatsoever on the basis of religion", government lawyers argued in a filing.
Enjoy the magical vernal equinox! While it is already meteorological spring , most consider spring to begin on the Spring Equinox. There's always someplace where the sun is directly overhead, but it only occurs exactly at the equator on the equinox.
The accident comes 11 years after Hammond was left in a coma following a high-speed smash while filming for the BBC show in 2006. The Grand Tour Crew raced to Richard's aid, mindful that he suffered serious brain damage in a 288mph collision 11 years back.
Zaterman says the cuts, which need congressional approval, would add to an already severe housing shortage for the poor. This would be enough money for pilot projects to determine the best methods to build the wall, according to Mr.
The test of a new high-thrust rocket engine was hailed as a "great leap forward" by North Korea, state media reported Sunday. Trump made the comments to reporters while departing his Mar-a-Lago resort in Florida, US, where he spent the weekend.
Nordqvist finished at 25-under 263, two strokes off the LPGA Tour record that Sei Young Kim matched a year ago at Desert Ridge. She won at Desert Ridge in 2013 to reach No. 1, was second in 2014 and 2015 and tied for fourth past year .
As Human Services commissioner, Piper is focused on ensuring access to health care for those enrolled in public programs. However, Noseworthy wanted the employees to apply discretion when two patients are referred with similar conditions.